Cargando…
Treatment advances in systemic juvenile idiopathic arthritis
Systemic juvenile idiopathic arthritis (JIA) is an autoinflammatory condition that is distinct from other forms of childhood arthritis. Recently, biologic agents that specifically inhibit the cytokines interleukin (IL)-1 and IL-6 have demonstrated remarkable clinical effectiveness and confirmed the...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Faculty of 1000 Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974570/ https://www.ncbi.nlm.nih.gov/pubmed/24765526 http://dx.doi.org/10.12703/P6-21 |
| _version_ | 1782479484038938624 |
|---|---|
| author | Beukelman, Timothy |
| author_facet | Beukelman, Timothy |
| author_sort | Beukelman, Timothy |
| collection | PubMed |
| description | Systemic juvenile idiopathic arthritis (JIA) is an autoinflammatory condition that is distinct from other forms of childhood arthritis. Recently, biologic agents that specifically inhibit the cytokines interleukin (IL)-1 and IL-6 have demonstrated remarkable clinical effectiveness and confirmed the importance of these cytokines in the disease process. Future studies are likely to optimize the care of children with systemic arthritis and further elucidate the disease pathogenesis. |
| format | Online Article Text |
| id | pubmed-3974570 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Faculty of 1000 Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39745702014-04-24 Treatment advances in systemic juvenile idiopathic arthritis Beukelman, Timothy F1000Prime Rep Review Article Systemic juvenile idiopathic arthritis (JIA) is an autoinflammatory condition that is distinct from other forms of childhood arthritis. Recently, biologic agents that specifically inhibit the cytokines interleukin (IL)-1 and IL-6 have demonstrated remarkable clinical effectiveness and confirmed the importance of these cytokines in the disease process. Future studies are likely to optimize the care of children with systemic arthritis and further elucidate the disease pathogenesis. Faculty of 1000 Ltd 2014-04-01 /pmc/articles/PMC3974570/ /pubmed/24765526 http://dx.doi.org/10.12703/P6-21 Text en © 2014 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Review Article Beukelman, Timothy Treatment advances in systemic juvenile idiopathic arthritis |
| title | Treatment advances in systemic juvenile idiopathic arthritis |
| title_full | Treatment advances in systemic juvenile idiopathic arthritis |
| title_fullStr | Treatment advances in systemic juvenile idiopathic arthritis |
| title_full_unstemmed | Treatment advances in systemic juvenile idiopathic arthritis |
| title_short | Treatment advances in systemic juvenile idiopathic arthritis |
| title_sort | treatment advances in systemic juvenile idiopathic arthritis |
| topic | Review Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974570/ https://www.ncbi.nlm.nih.gov/pubmed/24765526 http://dx.doi.org/10.12703/P6-21 |
| work_keys_str_mv | AT beukelmantimothy treatmentadvancesinsystemicjuvenileidiopathicarthritis |